TEATSEAL

देश: ऑस्ट्रेलिया

भाषा: अंग्रेज़ी

स्रोत: APVMA (Australian Pesticides and Veterinary Medicines Authority)

सक्रिय संघटक:

BISMUTH SUBNITRATE

थमां उपलब्ध:

ZOETIS AUSTRALIA PTY LTD

INN (इंटरनेशनल नाम):

bismuth subnitrate(650mg/g)

फार्मास्यूटिकल फॉर्म:

MISC. INTRA MAMMARY

रचना:

BISMUTH SUBNITRATE MINERAL-BISMUTH Active 650.0 mg/g

पैकेज में यूनिट:

120 x 4g; applicator

वर्ग:

VM - Veterinary Medicine

द्वारा बनाया गया:

ZOETIS AUSTRALIA

चिकित्सीय समूह:

DAIRY CATTLE - NON-LACTATING (DRY) PERIO

चिकित्सीय क्षेत्र:

MISCELLANEOUS VETERINARY

चिकित्सीय संकेत:

MASTITIS | SUBCLINICAL MASTITIS

उत्पाद समीक्षा:

Poison schedule: 0; Withholding period: WITHHOLDING PERIOD: MILK: DO NOT USE in lactating cows or within 4 days of calvi ng. After calving, colostrum or milk fro m treated dry cows. MUST NOT BE USED for human consumption or processing for 96 hours (8 milkings). MEAT: ZERO (0) DAY S ESI: ESI not required; Host/pest details: DAIRY CATTLE - NON-LACTATING (DRY) PERIO: [MASTITIS]; For the prevention of clinical & sub-clinical mastitis in dairy cows during the non-lactating (dry) period and early post-calving.DO NOT USE in lactating cows or within 4 days of calving. After calving, colostrum or milk from treated dry cows MUST NOT BE USED for human consumption or processing for 96 hours (8 milkings).

प्राधिकरण का दर्जा:

Registered

प्राधिकरण की तारीख:

2023-07-01

सूचना पत्रक

Company Name:
Product Name:
APVMA Approval No:
ZOETIS AUSTRALIA PTY LTD
TEATSEAL
51357/106869
Label Name:
TEATSEAL
Signal Headings:
FOR ANIMAL TREATMENT ONLY
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
Constituent
Statements:
650 mg/g BISMUTH SUBNITRATE
Claims:
For the prevention of clinical and subclinical mastitis in dairy cows
during the non-lactating
(dry) period and early post-calving.
Net Contents:
120 x 4g applicator
Directions for Use:
Restraints:
DO NOT USE in lactating cows
Dosage and
Administration:
During the administration of the product it is important to ensure
that infection is not
introduced. Accidental introduction of bacteria into the quarter
during insertion of the
intramammary syringe can result in serious mastitis. Thoroughly clean
hands prior to
administration and wear clean gloves during administration.
Immediately after the last
milking at drying off, prior to treatment with Teatseal, the udder
should be stripped and
each teat thoroughly cleaned with a suitable disinfectant.
Carefully infuse the entire contents of one injector into each teat to
form a seal, preventing
the ingress of pathogenic bacteria into the udder during the dry
period.
After infusion do not massage or squeeze the teat as this may dislodge
the seal.
It is recommended that Teatseal be used as part of a herd approach to
dry cow
management and mastitis control. Cows considered likely to be free of
subclinical mastitis
and at risk for new infection in the dry period should be given
Teatseal at drying off. Other
animals should be managed in accordance with an approved mastitis
control plan or
specific veterinary advice. RLP APPROVED
For practical purposes, selection criteria may be based on the
mastitis and cell count
history of individual cows, or recognised tests for the detection of
subclinical mastitis, or
bacteriological sampling. As a guide, where there has been no episode
of clinical mastitis
and at least three individual cow cell counts are available, cows with
all cell counts below
250,000 cells/mL may be given

उत्पाद विशेषताएं

PRODUCT NAME: TEATSEAL
PAGE: 1 OF 5
This revision issued: April, 2013
SAFETY DATA SHEET
Issued by: Pfizer Animal Health Australia Pty Ltd
Phone: [phone]
POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800
764 766 IN NEW ZEALAND)
SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER
Pfizer Animal Health Australia Pty Ltd
38-42 Wharf Road
West Ryde NSW 2114
Tel: [phone]
Fax: [phone]
__________________________________________________________
PFIZER ANIMAL HEALTH AUSTRALIA PTY LTD
ABN 94 156 476 425
CHEMICAL NATURE:
Veterinary health care product.
TRADE NAME:
TEATSEAL
APVMA CODE:
51357
PRODUCT USE:
For the prevention of mastitis in dairy cows during the non-lactating
(dry) period. See
product label for instructions regarding application.
CREATION DATE:
MAY, 2002
THIS VERSION ISSUED:
APRIL, 2013
and is valid for 5 years from this date.
SECTION 2 - HAZARDS IDENTIFICATION
STATEMENT OF HAZARDOUS NATURE
This product is classified as:
Not classified as hazardous according to the criteria of SWA
Australia.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
Not Hazardous - No criteria found.
SUSMP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good.
UN NUMBER:
None allocated
GHS SIGNAL WORD: NONE. NOT HAZARDOUS.
PREVENTION
P102: Keep out of reach of children.
P235: Keep cool.
RESPONSE
P353: Rinse skin or shower with water.
P301+P330+P331: IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P332+P313: If skin irritation occurs: Get medical advice.
P337+P313: If eye irritation persists: Get medical advice.
P370+P378: Not combustible. Use extinguishing media suited to burning
materials.
STORAGE
P401: Store in the closed original container.
DISPOSAL
P501: Dispose of small quantities and empty containers by wrapping
with paper and putting in garbage. For
larger quantities, if recycling or reclaiming is not possible, use a
commercial waste disposal service.
E
E
E
M
M
M